Overall rank by patents
#24,083
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 1 technology areas, recorded in grant years 2024–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
According to USPTO PatentsView, Chainalysis ranks #24,083 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 1 technology areas.
USPTO PatentsView assignee plate
Corpus R24083 · US Corporation #24,083 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Cellview Imaging Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Medallion Instrument… · near
34 score
Skyworks Panasonic F… · near
34 score
Chainalysis · this assignee
34 score
Intact Vascular · near
34 score
SMR Inventec · near
34 score
3D Lighting Innovati… · lowest
7 score
What this shows Chainalysis's Innovation Score is 33.6/100 (top 55% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Chainalysis, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 9.1% of grants classified under H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). By volume, Chainalysis sits between Cellview Imaging Inc. and Chenguang Biotech Group Co., Ltd..
Chainalysis, Inc. shows 11 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cellview Imaging Inc.
11 patents
Centera Photonics Inc.
11 patents
Ceramic Data Solutions GmbH
11 patents
CertainTeed Canada, Inc.
11 patents
Changchun Meihe Science and Technology Development Co., Ltd.
11 patents
Chargerback, Inc.
11 patents
Chemometec A/S
11 patents
Chenguang Biotech Group Co., Ltd.
11 patents
Chainalysis, Inc.
11 patents
What this shows Chainalysis holds 11 patents at rank #24,127, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,127 in granted patent volume.
Other assignees with the most granted patents in Chainalysis's primary technology class.
Two PlainPatent-derived peer sets for Chainalysis, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (34 here).
Chainalysis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
34 Top 55% higher than 45% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 11 | 100.0% |
Top 1 of 1 technology areas
Overall rank by patents
#24,083
of 50,000 tracked assignees
33.6 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.